Type(s) of Cancer
Uterine
Uterine
Study Phase
Phase 3
Study Completion Date
September 2015
September 2015
NCT01012297Uploaded 08-21-2020
Access via NCI by Request
PDS UID: nci-data-422
A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus
Files: NCT01012297-D1



Data DictionaryNCT01012297-D1-Data-Dictionary_3.pdf

DATANCT01012297-D1-Dataset_2.csv

OTHERREADME.pdf